Related Experiment Video
Updated: Aug 23, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir
Elinore F McCance-Katz1, Petrie M Rainey, Patrick Smith
1Medical College of Virginia, Virginia Commonwealth University, PO Box 980109, Richmond, VA 23298, USA. emccancekatz@vcu.edu
Abstract:
Understanding drug interactions between antiretrovirals and opiate therapies may decrease toxicities and enhance adherence, with improved HIV outcomes in injection drug users. We report results of a clinical pharmacology study designed to examine the interaction of the protease inhibitor, nelfinavir, with methadone and LAAM (N = 48). Nelfinavir decreased methadone exposure, but no withdrawal was observed over the five day study period. LAAM and dinorLAAM concentrations were decreased, while norLAAM concentrations were increased, with minimal overall change in LAAM/metabolite exposure. Methadone and LAAM did not affect nelfinavir concentrations, but methadone decreased M8 metabolite exposure. While no toxicities were observed, clinicians should be aware of the potential for drug interactions when patients require treatment with nelfinavir and these opiate medications.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug toxicity: Drug–Drug Interaction
Opioid Analgesics: Morphine and Other Natural Cogeners
Antiviral Nucleoside Inhibitors
Pharmacokinetics: Drug–Drug Interactions

